Mayne Pharma Group Limited (ASX: MYX)
Australia
· Delayed Price · Currency is AUD | Market Cap | 339.20M |
| Revenue (ttm) | 388.40M |
| Net Income (ttm) | -174.23M |
| Shares Out | 81.15M |
| EPS (ttm) | -2.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 526,385 |
| Open | 4.420 |
| Previous Close | 4.450 |
| Day's Range | 4.020 - 4.460 |
| 52-Week Range | 3.740 - 7.460 |
| Beta | 1.24 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 25, 2024 |
About Mayne Pharma Group
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through three segments: Women’s Health, Dermatology, and International. It provides oral drug delivery systems; and contract development and manufacturing services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease the... [Read more]
Financial Performance
Financial StatementsNews
FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH
Proposed Ruling Aims to Eliminate Out-of-Pocket Costs for Contraception, Enhancing Access for Women in the United States ADELAIDE, Australia and RALEIGH, N.C. , Nov. 4, 2024 /PRNewswire/ -- Mayne Phar...
Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement
Mayne Pharma has filed a patent infringement lawsuit against Indian drugmaker Sun Pharma in a U.S. court, the Australian drugmaker said on Thursday.
Mayne Pharma Group Limited (MAYNF) Q2 2024 Earnings Call Transcript
Mayne Pharma Group Limited (OTCPK:MAYNF) Q2 2024 Results Conference Call February 25, 2024 5:00 PM ET